
Windtree Therapeutics WINT
Quartalsbericht 2025-Q3
hinzugefügt 19.11.2025
Windtree Therapeutics DPO 2011-2026 | WINT
DPO Jährlich Windtree Therapeutics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | 145 | - | 983 | 265 | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 983 | 145 | 464 |
DPO anderer Aktien in der Pharmaeinzelhändler
| Name | DPO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
199 | $ 9.33 | 1.41 % | $ 603 M | ||
|
I-Mab
IMAB
|
2.24 K | - | - | $ 866 M | ||
|
Midatech Pharma plc
MTP
|
162 | - | -18.52 % | $ 27.3 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
78.2 | - | - | $ 40.3 B | ||
|
Aptorum Group Limited
APM
|
405 | $ 0.87 | -2.13 % | $ 6.4 M | ||
|
ACADIA Pharmaceuticals
ACAD
|
75.2 | $ 22.38 | 0.81 % | $ 3.71 B | ||
|
Galapagos NV
GLPG
|
81.9 | $ 28.15 | 1.04 % | $ 2.69 B | ||
|
Advaxis
ADXS
|
143 K | - | -9.65 % | $ 45.9 M | ||
|
Harmony Biosciences Holdings
HRMY
|
28.9 | $ 30.95 | -0.34 % | $ 1.78 B | ||
|
Институт стволовых клеток человека
ISKJ
|
115 | - | - | - | ||
|
ImmuCell Corporation
ICCC
|
19.5 | $ 8.43 | -0.12 % | $ 76.1 M | ||
|
Incyte Corporation
INCY
|
200 | $ 98.55 | -0.55 % | $ 19.2 B | ||
|
InMed Pharmaceuticals
INM
|
129 | $ 0.71 | 1.27 % | $ 1.74 M | ||
|
Aeterna Zentaris
AEZS
|
34.4 K | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
9.04 K | - | -10.17 % | $ 12.2 K | ||
|
Jaguar Health
JAGX
|
676 | $ 7.34 | -6.79 % | $ 17.1 M | ||
|
AIkido Pharma
AIKI
|
1.92 | - | 1.93 % | $ 17.4 M | ||
|
KalVista Pharmaceuticals
KALV
|
1.03 K | $ 26.68 | 0.02 % | $ 1.44 B | ||
|
Kamada Ltd.
KMDA
|
106 | $ 8.16 | 0.68 % | $ 260 M | ||
|
Ligand Pharmaceuticals Incorporated
LGND
|
77.8 | $ 220.06 | -2.13 % | $ 4.02 B | ||
|
Liquidia Corporation
LQDA
|
209 | $ 38.41 | 0.67 % | $ 3.31 B | ||
|
Ampio Pharmaceuticals
AMPE
|
2.85 K | - | -11.43 % | $ 502 K | ||
|
Aquestive Therapeutics
AQST
|
395 | $ 4.08 | 0.62 % | $ 436 M | ||
|
Arcutis Biotherapeutics
ARQT
|
133 | $ 23.15 | 3.49 % | $ 2.95 B |